159 related articles for article (PubMed ID: 11472734)
1. Effect of calcium channel blockers on proteoglycan synthesis by vascular smooth muscle cells and low density lipoprotein--proteoglycan interaction.
Vijayagopal P; Subramaniam P
Atherosclerosis; 2001 Aug; 157(2):353-60. PubMed ID: 11472734
[TBL] [Abstract][Full Text] [Related]
2. Effect of hypoxia and hypoxia/reoxygenation on proteoglycan metabolism by vascular smooth muscle cells.
Figueroa JE; Tao Z; Sarphie TG; Smart FW; Glancy DL; Vijayagopal P
Atherosclerosis; 1999 Mar; 143(1):135-44. PubMed ID: 10208488
[TBL] [Abstract][Full Text] [Related]
3. Varied low density lipoprotein binding property of proteoglycans synthesized by vascular smooth muscle cells cultured on extracellular matrix.
Vijayagopal P; Menon PV
Atherosclerosis; 2005 Jan; 178(1):75-82. PubMed ID: 15585203
[TBL] [Abstract][Full Text] [Related]
4. Arterial smooth muscle cell proteoglycans synthesized in the presence of glucosamine demonstrate reduced binding to LDL.
Tannock LR; Little PJ; Wight TN; Chait A
J Lipid Res; 2002 Jan; 43(1):149-57. PubMed ID: 11792734
[TBL] [Abstract][Full Text] [Related]
5. Enhanced synthesis and accumulation of proteoglycans in cholesterol-enriched arterial smooth muscle cells.
Vijayagopal P
Biochem J; 1993 Sep; 294 ( Pt 2)(Pt 2):603-11. PubMed ID: 8373376
[TBL] [Abstract][Full Text] [Related]
6. Vascular smooth muscle cell migration, atherosclerosis, and calcium channel blockers.
Schachter M
Int J Cardiol; 1997 Dec; 62 Suppl 2():S85-90. PubMed ID: 9488199
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the atherogenic properties of vascular smooth muscle proteoglycans by oral anti-hyperglycemic agents.
de Dios ST; Frontanilla KV; Nigro J; Ballinger ML; Ivey ME; Cawson EA; Little PJ
J Diabetes Complications; 2007; 21(2):108-17. PubMed ID: 17331859
[TBL] [Abstract][Full Text] [Related]
8. Effects of calcium antagonists on low density lipoprotein metabolism in human arterial smooth muscle cells.
Mori S; Ito H; Yamamoto K
Tohoku J Exp Med; 1988 Apr; 154(4):329-33. PubMed ID: 3188001
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II stimulates synthesis of vascular smooth muscle cell proteoglycans with enhanced low density lipoprotein binding properties.
Figueroa JE; Vijayagopal P
Atherosclerosis; 2002 Jun; 162(2):261-8. PubMed ID: 11996945
[TBL] [Abstract][Full Text] [Related]
10. Androgens stimulate human vascular smooth muscle cell proteoglycan biosynthesis and increase lipoprotein binding.
Hashimura K; Sudhir K; Nigro J; Ling S; Williams MR; Komesaroff PA; Little PJ
Endocrinology; 2005 Apr; 146(4):2085-90. PubMed ID: 15661861
[TBL] [Abstract][Full Text] [Related]
11. Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-beta1 exhibit increased binding to LDLs.
Little PJ; Tannock L; Olin KL; Chait A; Wight TN
Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):55-60. PubMed ID: 11788461
[TBL] [Abstract][Full Text] [Related]
12. Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells.
Camejo G; Fager G; Rosengren B; Hurt-Camejo E; Bondjers G
J Biol Chem; 1993 Jul; 268(19):14131-7. PubMed ID: 8314779
[TBL] [Abstract][Full Text] [Related]
13. Calcium antagonists and vascular smooth muscle cell reactivity.
Marche P; Stepien O
Z Kardiol; 2000; 89 Suppl 2():140-4. PubMed ID: 10769418
[TBL] [Abstract][Full Text] [Related]
14. Modulation of proteoglycan synthesis by bovine vascular smooth muscle cells during cellular proliferation and treatment with heparin.
Williams SP; Mason RM
Arch Biochem Biophys; 1991 Jun; 287(2):386-96. PubMed ID: 1716868
[TBL] [Abstract][Full Text] [Related]
15. Thrombin regulates vascular smooth muscle cell proteoglycan synthesis via PAR-1 and multiple downstream signalling pathways.
Ivey ME; Little PJ
Thromb Res; 2008; 123(2):288-97. PubMed ID: 18571697
[TBL] [Abstract][Full Text] [Related]
16. Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner.
Wilson PG; Thompson JC; Webb NR; de Beer FC; King VL; Tannock LR
Am J Pathol; 2008 Dec; 173(6):1902-10. PubMed ID: 18974302
[TBL] [Abstract][Full Text] [Related]
17. Effect of serum withdrawal on the contribution of L-type calcium channels (CaV1.2) to intracellular Ca2+ responses and chemotaxis in cultured human vascular smooth muscle cells.
Patel MK; Clunn GF; Lymn JS; Austin O; Hughes AD
Br J Pharmacol; 2005 Jul; 145(6):811-7. PubMed ID: 15880143
[TBL] [Abstract][Full Text] [Related]
18. Effect of low-density lipoproteins on the synthesis and secretion of proteoglycans by human endothelial cells in culture.
Vijayagopal P; Srinivasan SR; Dalferes ER; Radhakrishnamurthy B; Berenson GS
Biochem J; 1988 Oct; 255(2):639-46. PubMed ID: 3202837
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of Ki11502 as a potent inhibitor of PDGF beta receptor-mediated proteoglycan synthesis in vascular smooth muscle cells.
Getachew R; Ballinger ML; Burch ML; Little PJ; Osman N
Eur J Pharmacol; 2010 Jan; 626(2-3):186-92. PubMed ID: 19818754
[TBL] [Abstract][Full Text] [Related]
20. Macrophage secretory products selectively stimulate dermatan sulfate proteoglycan production in cultured arterial smooth muscle cells.
Edwards IJ; Wagner WD; Owens RT
Am J Pathol; 1990 Mar; 136(3):609-21. PubMed ID: 2316626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
